HomeTRVI • NASDAQ
add
Trevi Therapeutics Inc
Previous close
$6.47
Day range
$6.22 - $6.45
Year range
$2.30 - $7.39
Market cap
556.93M USD
Avg Volume
3.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.24M | 37.05% |
Net income | -11.42M | -45.95% |
Net profit margin | — | — |
Earnings per share | -0.11 | -37.50% |
EBITDA | -12.20M | -37.17% |
Effective tax rate | -0.14% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 107.62M | 29.71% |
Total assets | 110.90M | 24.05% |
Total liabilities | 11.26M | 64.18% |
Total equity | 99.64M | — |
Shares outstanding | 96.68M | — |
Price to book | 6.10 | — |
Return on assets | -34.04% | — |
Return on capital | -38.08% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -11.42M | -45.95% |
Cash from operations | -9.55M | -50.18% |
Cash from investing | -23.87M | -285.85% |
Cash from financing | 51.47M | 95,409.26% |
Net change in cash | 18.04M | 180.55% |
Free cash flow | -8.86M | -152.88% |
About
Founded
2011
Headquarters
Website
Employees
27
